KA

Kunal Arun Parekh

Director Director DIN 07008752
DIN 07008752 First appointment Dec 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Kunal Arun Parekh

Data last updated:

Kunal Arun Parekh was a Director at Us Amino Private Limited (2014–2015) and Director at Aadia Bio Science Limited (from 2020). The companies operate in Pharma.

DIN 07008752
Primary Designation Director
Industry Pharma
First Appointment 22 Dec 2014
Oldest Company Age 6 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Us Amino Private Limited U24232RJ2014PTC046771
Director22 Dec 20142014₹24.84 Cr (FY 2024)Active
Aadia Bio Science Limited U24110MH2020PLC349096
Director29 Oct 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aadia Bio Science Limited
Us Amino Private Limited
Premium access

Shareholding and investment profile for Kunal Arun Parekh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kunal Arun Parekh

Kunal Arun Parekh was first appointed on 22 Dec 2014 as Director at Us Amino Private Limited. The most recent appointment on record is 29 Oct 2020 at Aadia Bio Science Limited.

Kunal Arun Parekh held 2 earlier board appointments: Us Amino Private Limited (Director, 22 Dec 2014 to 09 Sep 2015); Aadia Bio Science Limited (Director, from 29 Oct 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available